Cambridge, MA · Founded 2020 · Privately Held (backing)
Developer of a diagnostics platform designed to provide fast and accurate results in molecular diagnostics. Sunbird Bio is based in Cambridge, MA and was founded in 2020. Its last reported valuation was $16 million in Nov 2022. It has raised $27.3 million across 1 recorded round; the latest was a $23.2 million early-stage round in Apr 2023.
Last reported valuation
$16.0M
Oct 2026
Priced at
—
Total raised
$27.3M
Last round
Early Stage VC
Apr 2023
No prints on record
No secondary trades in Sunbird Bio shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of Sunbird Bio with a free Private Market View account
·The complete investor list: 11 names
·Watch Sunbird Bio: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Sunbird Bio stock.
